Active ingredientVerteporfinCat. No. P-V033-001CAS 129497-78-5Family · Pharmaceutical analytical standards
Verteporfin
A benzoporphyrin-derived photosensitiser, discovered in the mid-1980s by the group of Julia Levy, a professor at the University of British Columbia, and approved in the United States in 2000 for photodynamic therapy of wet macular degeneration. This family brings together the active ingredient.
Did you know?It is activated by non-thermal red light at 689 nanometres: the laser aimed at the eye switches it on in the abnormal blood vessels where it accumulates, and the singlet oxygen produced closes them.
Go to the active ingredient →Active ingredientVerteporfinCat. No. P-V033-001CAS 129497-78-5No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.